ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ENDP Endo International PLC

0.2926
0.00 (0.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Endo International PLC NASDAQ:ENDP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.2926 0.29 0.294 0 01:00:00

Endo to Announce Fourth-Quarter and Full-Year 2016 Financial Results

13/02/2017 12:30pm

PR Newswire (US)


Endo (NASDAQ:ENDP)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Endo Charts.

DUBLIN, Feb. 13, 2017 /PRNewswire/ -- Endo International plc (NASDAQ / TSX: ENDP) will announce its fourth-quarter and full-year 2016 financial results and provide an update on its ongoing corporate strategic review on February 28, 2017. Members of its senior management team will host a conference call and webcast before the U.S. financial markets open at 8:30 a.m. ET.

The dial-in number to access the call is U.S./Canada (866) 497-0462, International (678) 509-7598, and the passcode is 58581981. Please dial in 10 minutes prior to the scheduled start time.     

A replay of the call will be available from February 28, 2017 at 11:30 a.m. ET until 12:30 p.m. ET on March 14, 2017 by dialing U.S./Canada (855) 859-2056, International (404) 537-3406, and entering the passcode 58581981.    

A simultaneous webcast of the call can be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 12:30 p.m. ET on March 14, 2017. The replay can be accessed by clicking the Investor Relations section of the website.

About Endo International plc
Endo International plc (NASDAQ / TSX: ENDP) is a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded and generic pharmaceutical products as well as over-the-counter medications through its operating companies. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endo-to-announce-fourth-quarter-and-full-year-2016-financial-results-300406024.html

SOURCE Endo International plc

Copyright 2017 PR Newswire

1 Year Endo Chart

1 Year Endo Chart

1 Month Endo Chart

1 Month Endo Chart

Your Recent History

Delayed Upgrade Clock